Adrenocorticotrophic-hormone deficiency in chronic myelogenous leukemia after treatment.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000309:Adrenal Insufficiency / Q000139:chemically induced*; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D000493:Allopurinol / Q000009:adverse effects*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects*; D008797:Metyrapone
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000493:Allopurinol; D000324:Adrenocorticotropic Hormone; D015122:Mercaptopurine; D006854:Hydrocortisone; D008797:Metyrapone